Kristen Ciombor (@kristenciombor) 's Twitter Profile
Kristen Ciombor

@kristenciombor

GI Med Onc at Vanderbilt @VUMC; wife and mom of 2 daughters; ASCO FCOI: bit.ly/40sTEyG

ID: 1604902940

linkhttp://vanderbilthealth.com/cancer/ calendar_today19-07-2013 02:46:44

964 Tweet

2,2K Takipçi

2,2K Takip Edilen

Kristen Ciombor (@kristenciombor) 's Twitter Profile Photo

One of the most amazing and under recognized aspects of ASCO is its incredible staff that make these meetings and the organization run so well. Much deserved shout out to Tony Schweizer and his colleagues for making this an incredible meeting! #GI25

One of the most amazing and under recognized aspects of <a href="/ASCO/">ASCO</a> is its incredible staff that make these meetings and the organization run so well. Much deserved shout out to <a href="/TonsterPS/">Tony Schweizer</a> and his colleagues for making this an incredible meeting! #GI25
Shaalan Beg MD MBA FASCO (@shaalanbeg) 's Twitter Profile Photo

Is 2025 going to be the year Pan-RAS inhibitors make it into the clinic? Pan-RAS inhibitor shows early/deep molecular response (and 36% response rate) for G12X mutated pancreatic cancer. (Significant AEs: rash, diarrhea, nausea, vomiting) dailynews.ascopubs.org/do/pan-ras-inh…

Is 2025 going to be the year Pan-RAS inhibitors make it into the clinic? 

Pan-RAS inhibitor shows early/deep molecular response (and  36% response rate) for G12X mutated pancreatic cancer. 
(Significant AEs: rash, diarrhea, nausea, vomiting)

dailynews.ascopubs.org/do/pan-ras-inh…
Kristen Ciombor (@kristenciombor) 's Twitter Profile Photo

Adding to our data of neoadjuvant pembro in MSI-H/dMMR colon cancer at CRC rapid abstracts -pCR rate of 44% after one dose! #GI25

Adding to our data of neoadjuvant pembro in MSI-H/dMMR colon cancer at CRC rapid abstracts -pCR rate of 44% after one dose! #GI25
Kristen Ciombor (@kristenciombor) 's Twitter Profile Photo

Front row seats to BREAKWATER data—improved ORR and DOR with enco/cetux plus FOLFOX when compared to SOC in 1L BRAF mut mCRC. #GI25

Front row seats to BREAKWATER data—improved ORR and DOR with enco/cetux plus FOLFOX when compared to SOC in 1L BRAF mut mCRC. #GI25
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Straight from #GI25 in Nature Medicine By Scott Kopetz Dr. Cathy Eng & colleagues Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial nature.com/articles/s4159… Trial met one of the dual primary endpoints (objective response rate) with

Straight from #GI25 in <a href="/NatureMedicine/">Nature Medicine</a> 
By <a href="/skopetz/">Scott Kopetz</a> <a href="/CathyEngMD/">Dr. Cathy Eng</a> &amp; colleagues 
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
nature.com/articles/s4159…
Trial met one of the dual primary endpoints (objective response rate) with
Kristen Ciombor (@kristenciombor) 's Twitter Profile Photo

Much awaited nivo/ipi vs nivo data from CheckMate 8HW in 1L MSI-H mCRC - nivo/ipi better in PFS and ORR across all lines of therapy with expected increase in toxicity #GI25 Concomitant publication in the Lancet today for more details!

Much awaited nivo/ipi vs nivo data from CheckMate 8HW in 1L MSI-H mCRC - nivo/ipi better in PFS and ORR across all lines of therapy with expected increase in toxicity #GI25 
Concomitant publication in the Lancet today for more details!
Tanios Bekaii-Saab, MD (@gicancerdoc) 's Twitter Profile Photo

Join us April 4-5 in Santa Barbara (or via livestream) for Gastrointestinal Cancers 2025! Speaker experts will cover the latest updates in treatment of the whole spectrum of GI cancers. Program schedule & registration: tinyurl.com/3a8zpdyf #pancreascancer #colorectalcancer

Join us April 4-5 in Santa Barbara (or via livestream) for Gastrointestinal Cancers 2025! Speaker experts will cover the latest updates in treatment of the whole spectrum of GI cancers. Program schedule &amp; registration: tinyurl.com/3a8zpdyf
#pancreascancer #colorectalcancer
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🔥🚨HOT OFF THE PRESS Just published Journal of Clinical Oncology IMPORTANT SPECIAL ARTICLE & #Recommendations for #Academic #MedicalCenters by ASCO on: Promoting Reasonable #CareerExpectations & Maximizing Professional Fulfillment for #Academic #Oncologists PLZ SHARE👇🏻 ascopubs.org/doi/10.1200/JC…

🔥🚨HOT OFF THE PRESS
Just published <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>

IMPORTANT SPECIAL ARTICLE 
&amp; #Recommendations for #Academic #MedicalCenters by <a href="/ASCO/">ASCO</a> on:

Promoting Reasonable #CareerExpectations &amp; Maximizing
Professional Fulfillment for #Academic #Oncologists

PLZ SHARE👇🏻
ascopubs.org/doi/10.1200/JC…
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

Happy #DoctorsDay to ALL my colleagues for all your hard work, diligence, collegiality and friendship! #cancer #cancerresearch #academia #grateful 🙏 @VUMC_Cancer Vanderbilt University Medical Center @VUMCHemOnc

Happy #DoctorsDay to ALL my colleagues for all your hard work, diligence, collegiality and friendship! #cancer #cancerresearch #academia #grateful 🙏 @VUMC_Cancer <a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a> @VUMCHemOnc
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

So delighted to work with 🤩Jeneth Aquino, our amazing GI clinic APP who represents Vanderbilt University Medical Center #Nashville Chapter at the annual Oncology Nursing Society. She’s an amazing colleague!! Heather Jackson, PhD, APRN, FAANP. #cancer #PatientCare #CancerResearch

So delighted to work with 🤩Jeneth Aquino, our amazing GI clinic APP who represents <a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a> #Nashville Chapter at the annual <a href="/oncologynursing/">Oncology Nursing Society</a>.  She’s an amazing colleague!! <a href="/JacksonHeatherJ/">Heather Jackson, PhD, APRN, FAANP</a>.  #cancer #PatientCare #CancerResearch
OncLive.com (@onclive) 's Twitter Profile Photo

#OncologyFellows! Take your research to the next level. Submit your #GICancer abstract by 7/7 for a chance to join us in Austin this September! Connect with experts and gain invaluable experience. Tanios Bekaii-Saab, MD Rachna Shroff, MD, MS, FASCO Kristen Ciombor Submit now: hubs.li/Q03j5rtv0

#OncologyFellows! Take your research to the next level. Submit your #GICancer abstract by 7/7 for a chance to join us in Austin this September! Connect with experts and gain invaluable experience. <a href="/GIcancerDoc/">Tanios Bekaii-Saab, MD</a> <a href="/rachnatshroff/">Rachna Shroff, MD, MS, FASCO</a> <a href="/KristenCiombor/">Kristen Ciombor</a> 

Submit now: hubs.li/Q03j5rtv0
OncLive.com (@onclive) 's Twitter Profile Photo

#OncologyFellows, this is your opportunity to present your work, engage with peers, and advance your career! Submit your #GICancer essay by 7/7 for a trip to Austin this September! Don’t miss out! Tanios Bekaii-Saab, MD Rachna Shroff, MD, MS, FASCO Kristen Ciombor Apply now: hubs.li/Q03m3Xz10

#OncologyFellows, this is your opportunity to present your work, engage with peers, and advance your career! Submit your #GICancer essay by 7/7 for a trip to Austin this September! Don’t miss out! <a href="/GIcancerDoc/">Tanios Bekaii-Saab, MD</a> <a href="/rachnatshroff/">Rachna Shroff, MD, MS, FASCO</a> <a href="/KristenCiombor/">Kristen Ciombor</a> 

Apply now: hubs.li/Q03m3Xz10